The antiviral infusion Remdesivir was just revived as an early treatment for COVID. It can be expensive and hard to administer, but is useful when monoclonals and pills are in short supply like now.

The antiviral drug remdesivir can help keep unvaccinated people at risk of severe covid-19 out of hospitals, according to a study that found the treatment reduced hospitalization and death by 87 ...

In late December, as the omicron variant surged, the roster of early COVID-19 treatments was looking slim. Newly authorized pills for COVID-19 were in short supply. Several monoclonal antibody drugs ...

Self treatment of the respiratory tract using inhalation nebulizer. For a patient at high risk of severe Covid-19 related complications, newly released data shows that inhaled remdesivir offers the ...

With early treatment for COVID-19, many high-risk patients can avoid the hospital, but the limited supply of medicines has added to the stress on hospitals in this omicron surge. One antiviral ...